Avisi Technologies, an ophthalmic medical device company, has raised $10.7 million in a Series A funding round led by MedVenture Partners. Avisi plans to use the funding to support its SAPPHIRE clinical trial and to continue developing their pipeline of new treatments for all stages of glaucoma.
The NBC Changemakers list recognizes women transforming business and philanthropy across a varietyof sectors. Minna Song, CEO of EliseAI, led the company's $250 million Series E fundraising round last year, which doubled its valuation to $2.2 billion.
NexEos Bio announced that the U.S. Food and Drug Administration has cleared NexEos's Investigational New Drug Application to proceed to a Phase II/III clinical trial of NTX-1024 for the treatment of patients with the rare disease, vernal keratoconjunctivitis - a rare, severe ocular condition.
.png)
Concerto Biosciences announced a partnership with SACCO SYSTEM, a global leader in applied food microbiology. This partnership will pair Concerto's microbial intelligence platform with Sacco's heritage library of food-grade cultures, enabling the discovery of functional multi-microbe ingredients.
Alcatraz AI's Rock X facial authentication system has completed operational testing and evaluation conducted by the National Safe Skies Alliance at Daniel K. Inouye International Airport in Honolulu.
Another Tomorrow has joined the Aura Blockchain Consortium, setting the stage for an innovative shift in the fashion industry. The New York-based luxury label will debut the next generation of the nonprofit collective's digital product passport (DPP) across its Winter/Spring 2026 collection.
Nanodropper, the leader in micro-volume ophthalmic delivery, today announced that Bedo Solutions and Viseon Labs have agreed on terms to join its precision eyecare platform under a new corporate identity: Mu Medical.
Materna Medical, Inc., announced the establishment of a new ICD-10-PCS procedure code for the Ellora™ Obstetrical System by the Centers for Medicare & Medicaid Services, a significant step toward market access and reimbursement for labor and delivery innovation.
Grasshopper Bank has officially become the first community bank in the United States to integrate Anthropic's Model Context Protocol (MCP). This move allows the bank's business clients to perform complex, natural language financial analysis directly through AI assistants like Claude.
Zenflow, Inc. announced the U.S. Food and Drug Administration approval of the Zenflow Spring® Implant and Delivery System for the treatment of symptoms associated with benign prostatic hyperplasia, also known as enlarged prostate.
UNCAGED Innovations, the world's first biomaterial company to create a sustainable leather alternative from grains, today announced a partnership with Academy Award-winning actor and producer Natalie Portman.
Avisi Technologies, Inc., an ophthalmic medical device company advancing novel, sight-saving technologies, announces the first patient in the international SAPPHIRE Trial has been treated with Avisi's glaucoma treatment device VisiPlate®.
Sylvatex announced validated results for its novel precursor-free process for manufacturing lithium-iron-phosphate (LFP) cathode material, confirming over 50% lower capital expenditure (CapEx) cost and 35% lower total cost compared to conventional methods.
Avisi Technologies, Inc., an ophthalmic medical device company advancing novel, sight-saving technologies, presented positive twelve-month clinical data on VisiPlate® Aqueous Shunt from the VITA Trial during the 2025 American Academy of Ophthalmology annual meeting.
Concerto Biosciences, a clinical-stage biotech company developing microbial products for therapeutics and consumer markets, announced positive topline results from its first-in-human Phase 1b clinical trial evaluating ENS-002, a topical three-strain live biotherapeutic product for atopic dermatitis.
Avisi Technologies has received Investigational Device Exemption approval from the FDA for its glaucoma treatment device, VisiPlate. This milestone allows the company to launch the SAPPHIRE clinical trial, which will evaluate VisiPlate's safety and efficacy in patients with open-angle glaucoma.
Uncaged Innovations is reinventing plant-based leather alternatives by starting with the very foundation of animal leather: collagen. The result is Elevate, a material made with plant proteins that mimic collagen's fibril structure; it looks, feels, and performs like traditional leather.
Osteoporosis weakens bones as we age, affecting 50 million Americans, and women disproportionately. Osteoboost was inspired by technology used to provide the mechanical loading for astronauts to stay healthy in space. The FDA-cleared vibrating belt consistently reduced spinal bone loss by 85%.
Kind Designs' Living Seawalls are 3D-printed from a non-toxic concrete mixture, and can be custom-shaped to suit local flora and fauna: mangrove roots in Miami, barnacles and seagrass in New York. Their richly textured surfaces dissipate waves while providing habitats for sea life.
The National Kidney Foundation announced that its Innovation Fund has invested in BMI OrganBank, a medical device company pioneering next-generation organ preservation and assessment technologies. The funding will help finalize preparations for BMI OrganBank's clinical study of its machine platform.
Grasshopper Bank launched a first-of-its-kind Model Context Protocol server that enables its business banking clients to get personalized financial analysis through Claude, Anthropic's generative AI platform. The infrastructure sets the stage for future connectivity with other large language models.